Monopar Therapeutics
MNPR
#7582
Rank
โ‚ฌ0.44 B
Marketcap
65,30ย โ‚ฌ
Share price
-0.94%
Change (1 day)
-0.66%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -1,65ย โ‚ฌ

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -1,73ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,68ย โ‚ฌ an increase over its 2024 EPS that were of -3,73ย โ‚ฌ.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,65ย โ‚ฌ-1.87%
2025-1,68ย โ‚ฌ-54.99%
2024-3,73ย โ‚ฌ35.2%
2023-2,76ย โ‚ฌ-26.75%
2022-3,76ย โ‚ฌ13.7%
2021-3,31ย โ‚ฌ25.86%
2020-2,63ย โ‚ฌ28.89%
2019-2,04ย โ‚ฌ45.28%
2018-1,40ย โ‚ฌ-80.5%
2017-7,20ย โ‚ฌ1296.33%
2016-0,52ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,22ย โ‚ฌ-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA